We also studied TGF-β and TGF-β signaling-related components in the liver of AE patients both at the protein and mRNA levels, in order to assess the situation at the late stage of infection in resistant hosts where immune tolerance and development of fibrosis are combined. The gene discussed is TGFB1; the disease is infection.